Abbott Laboratories (ABT)

Working capital turnover

Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020
Revenue (ttm) US$ in thousands 41,950,000 41,217,000 40,725,000 40,326,000 40,109,000 39,959,000 40,226,000 41,505,000 43,653,000 45,030,000 45,548,000 44,514,000 43,075,000 42,308,000 40,233,000 37,338,000 34,608,000 32,221,000 31,444,000 32,095,000
Total current assets US$ in thousands 23,656,000 23,802,000 23,119,000 22,376,000 22,670,000 22,664,000 23,505,000 25,224,000 25,224,000 24,845,000 24,956,000 23,429,000 24,239,000 23,492,000 22,627,000 21,817,000 20,441,000 17,390,000 17,221,000 15,498,000
Total current liabilities US$ in thousands 14,157,000 14,902,000 13,760,000 14,021,000 13,841,000 13,042,000 14,350,000 15,489,000 15,489,000 13,365,000 12,392,000 12,647,000 13,105,000 12,867,000 12,614,000 12,462,000 11,907,000 10,257,000 10,959,000 10,808,000
Working capital turnover 4.42 4.63 4.35 4.83 4.54 4.15 4.39 4.26 4.48 3.92 3.63 4.13 3.87 3.98 4.02 3.99 4.06 4.52 5.02 6.84

December 31, 2024 calculation

Working capital turnover = Revenue (ttm) ÷ (Total current assets – Total current liabilities)
= $41,950,000K ÷ ($23,656,000K – $14,157,000K)
= 4.42

The working capital turnover of Abbott Laboratories has shown a decreasing trend over the past few years, indicating a potential inefficiency in managing its working capital. The ratio, which measures the company's ability to generate revenue relative to its working capital, has decreased from 6.84 as of March 31, 2020, to 4.42 as of December 31, 2024.

A declining working capital turnover could suggest difficulties in efficiently utilizing the company's current assets to support its operations and sales. This decrease may be a cause for concern as it implies that Abbott Laboratories may be taking longer to convert its working capital into sales revenue.

Management should closely monitor and analyze the components of working capital, such as inventory, accounts receivable, and accounts payable, to identify potential inefficiencies and implement strategies to improve working capital turnover and enhance overall operational efficiency.


See also:

Abbott Laboratories Working Capital Turnover (Quarterly Data)